JPS6078973A - Production of 1,5-benzothiazepine derivative - Google Patents

Production of 1,5-benzothiazepine derivative

Info

Publication number
JPS6078973A
JPS6078973A JP18677883A JP18677883A JPS6078973A JP S6078973 A JPS6078973 A JP S6078973A JP 18677883 A JP18677883 A JP 18677883A JP 18677883 A JP18677883 A JP 18677883A JP S6078973 A JPS6078973 A JP S6078973A
Authority
JP
Japan
Prior art keywords
formula
general formula
lower alkyl
group
aprotic polar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP18677883A
Other languages
Japanese (ja)
Inventor
Fumitake Shimada
文武 島田
Shun Ishiguro
石黒 駿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOSHIN CHEM KK
Original Assignee
TOSHIN CHEM KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOSHIN CHEM KK filed Critical TOSHIN CHEM KK
Priority to JP18677883A priority Critical patent/JPS6078973A/en
Publication of JPS6078973A publication Critical patent/JPS6078973A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain the titled compound useful as a coronary vasodilator, etc. in high yield in one stage, by condensing a partially novel specific propionic acid ester derivative with a halide of a tertiary amine in the presence of a metal hydride in an aprotic polar solvent. CONSTITUTION:A partially novel substance of formula I (Ar is phenyl substituted by a lower alkoxyl; R is H or lower acyl; R1 is lower alkyl) which is novel when R is lower acyl is condensed with a compound of formula II (R2 and R3 are lower alkyl; Y is lower alkylene; Z is halogen) in the presence of a metal hydride, e.g. sodium hydride, in an aprotic polar solvent, preferably dimethyl sulfoxide at 5-70 deg.C, preferably 10-40 deg.C to afford industrially and advantageously the aimed compound of formula III useful as medicines such as a psychotropic agent in addition to those described above or an intermediate thereof, etc.

Description

【発明の詳細な説明】 本発明は1.5−ベンゾチアゼピン誘導体の新規な製法
、さらに詳しくいえば、一般式(1)(式中のArは低
級アルコキンノ、(で置換さrしたフェニル基、Rは水
素原子又は低級アシルノ、(、R2及びR3はそれぞれ
低級アルキル基及びYは低級アルキレン基である〕 で示される1、5〜ペンゾチアゼピ/訪導体を、極めて
簡単な工程で収率よく経列的に製造する方法に関するも
のである。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides a novel method for producing 1,5-benzothiazepine derivatives. , R is a hydrogen atom or lower acylno, (R2 and R3 are each a lower alkyl group and Y is a lower alkylene group) 1,5-penzothiazepi/conductor represented by The present invention relates to a method for manufacturing in series.

前記一般式(1’)で示される1+5−ベンゾチアゼピ
ン誘導体の中には、冠血管・拡張作用や向精神作用など
の薬理作用のある医薬品や、あるいはその中間体として
有用な化合物が存在し、極めてM要な誘導体である。
Among the 1+5-benzothiazepine derivatives represented by the general formula (1'), there are compounds useful as pharmaceuticals with pharmacological effects such as coronary vasodilator and psychotropic effects, or as intermediates thereof. , is an extremely important derivative.

この一般式(1)で示される1、5−ベンゾチアゼピン
誘導体は、これ壇で提案されている多くの方法(特公昭
46−8982号公報、特公昭46−16749号公報
、慣公昭46〜4.3785号公報、特開昭57−13
6581号公報、特開昭58−99471号公報、特開
昭58−29779号公報など)に従って製造すること
ができる。
The 1,5-benzothiazepine derivative represented by the general formula (1) can be obtained by many methods proposed in the literature (Japanese Patent Publication No. 8982-1982, Japanese Patent Publication No. 16749-1974, Japanese Patent Publication No. 46-16749, 4.3785 Publication, JP-A-57-13
6581, JP-A-58-99471, JP-A-58-29779, etc.).

しかしながら、これらの方法はいずれも基本的(では次
に示すような工程の長い繁雑な方法であって、経済的に
満足しうる方法とはいえない□従来提案されている方法
に従って、一般式(1)で示される1、5−ベンゾチア
ゼピン誘導体を製造する場合、工程、は次のようになる
。すなわち、一般式(II) Ar (式中のAr及びRは前記と同じ意味をもち、R1は低
級アルキル基である) で示されるプロピオン酸エステル誘尋体を加水分jγ「
1〜て、一般式(Ill) Ar (式中のAr及びRは前記と同じ、は味をもつ)で示さ
れるプロピオン酸誘導体とし、次いで閉環して一般式収
) Ar (式中のAr及びRは前記と同じ忍法をもつ)で示され
る1、5−ベンゾチアゼピン誘導体とじた(式中のR2
、R5及びYは前記と同じ意味をもち、Zはハロゲン原
子である) で示される化合物と反応させ、必要に応じさらにアシル
化すれば、一般式(1)で示される1、5−ベンゾチア
ゼピン誘導体が得られる。
However, all of these methods are basic (but complicated methods with long steps as shown below), and cannot be said to be economically satisfactory methods. When producing the 1,5-benzothiazepine derivative represented by 1), the steps are as follows: General formula (II) Ar (wherein Ar and R have the same meanings as above, R1 is a lower alkyl group) The propionic acid ester derivative represented by
1 to 1 to form a propionic acid derivative represented by the general formula (Ill) Ar (Ar and R in the formula are the same as above, and have a taste), and then ring-closed to obtain the general formula) Ar (in the formula Ar and 1,5-benzothiazepine derivative (R has the same formula as above)
, R5 and Y have the same meanings as above, and Z is a halogen atom), and further acylation as required, the 1,5-benzothiamine represented by the general formula (1) can be obtained. An azepine derivative is obtained.

このように、従来提案式れている方法に従うと、工程が
長く(はん雑であって、経済的に不利である。
As described above, following the conventionally proposed method requires a long process (complicated) and is economically disadvantageous.

本発明者らは、このような従来提案されている方法の欠
点を改良し、短かい工程で経済的Gて有利に、前記一般
式(1)で示される1、5−ベンゾチアゼピン誘導体を
製造する方法を提供すべく鋭意研究を重ねた結果、非プ
ロトン性極性溶媒中水素化金属の存在下に、前記の一般
式(If)で示される化合物を一般式(V)で示される
化合物と縮合反応させることにより、1工程で一般式(
0で示される1、5−ベンゾチアゼピン誘導体が収率よ
く得られ、その目的を達成しうろことを見出し、この知
見に基づlハて本発明を完成するに至った。
The present inventors have improved the shortcomings of such conventionally proposed methods, and have advantageously produced the 1,5-benzothiazepine derivative represented by the general formula (1) in a short process and economically. As a result of intensive research to provide a method for producing the compound, the compound represented by the general formula (If) is combined with the compound represented by the general formula (V) in the presence of a metal hydride in an aprotic polar solvent. By carrying out a condensation reaction, the general formula (
It has been found that the 1,5-benzothiazepine derivative represented by 0 can be obtained in good yield and that the object can be achieved, and based on this knowledge, the present invention has been completed.

すなわち、本発明は、一般式(If) Ar (式中のArは低級アルキレ基で置換されたフェニル基
、Rは水素原子又は低級アシル基及びR1は低級アルキ
ル基である) で示される化合物を、非プロトン性極江浴媒中水素化金
属の存在下に、一般式(■) (式中のR2及びR3はそれぞれ低級アルギル基、Yは
低級アルキレン基及び2はハロゲノ原子である) で示される化合物と縮合反応さぜることを’Cj jl
tとする、一般式(1) (式中のAr、 R,R2、R3及びYは前記と同じ意
味をもつ) で示される1、5−ベンゾチアゼピン誘導体の製法を提
供するものである。
That is, the present invention provides a compound represented by the general formula (If) Ar (wherein Ar is a phenyl group substituted with a lower alkylene group, R is a hydrogen atom or a lower acyl group, and R1 is a lower alkyl group) , in the presence of a hydrogenated metal in an aprotic polar bath medium, expressed by the general formula (■) (wherein R2 and R3 are each a lower argyl group, Y is a lower alkylene group, and 2 is a halogeno atom) 'Cj jl
The present invention provides a method for producing a 1,5-benzothiazepine derivative represented by the general formula (1) (wherein Ar, R, R2, R3, and Y have the same meanings as above), where t is represented by the following formula.

本発明方法において用いる前記一般式(■)で示される
化合物は、式中のArが低級アルコキン基で置換された
フェニル基、Rが水素原子又は低級アシル基及びR1が
低級アルキル基であるプロピオン酸エステル誘導体であ
って、前記の低級アルコキノ基としてはメトキシ基やエ
トキシ基などが、低級アシル基としてはアセチル基やプ
ロピオニル基などが、低級アルキル基としてはメチル基
やエチル基などが挙げられる。
The compound represented by the general formula (■) used in the method of the present invention is a propionic acid compound in which Ar is a phenyl group substituted with a lower alkoxy group, R is a hydrogen atom or a lower acyl group, and R1 is a lower alkyl group. In the ester derivatives, examples of the lower alkokino groups include methoxy and ethoxy groups, examples of the lower acyl groups include acetyl and propionyl groups, and examples of the lower alkyl groups include methyl and ethyl groups.

このプロピオン酸エステル誘導体のうち、前記一般式(
II)におけるRが水素原子である2−ヒドロキシプロ
ピオ/酸エステル誘導体は、公知の方法(特公昭45−
9383号公報)に従って製造することができる。
Among these propionic acid ester derivatives, the general formula (
The 2-hydroxypropio/acid ester derivative in which R in II) is a hydrogen atom can be prepared by a known method (Japanese Patent Publication No. 45-1989).
9383).

例えば、2−アミノチオフェノールと、一般式) (式中のAr及びR1は前記と同じ意味をもつ)で示さ
れるグリジット酸エステルとを無溶媒中100〜130
℃の温度で反応させることにより、目的とする2−ヒド
ロキシプロピオン酸エステル誘導体が得られる。このも
のには/ス型とトランス型の2種の立体異性体が存在す
るが、1)II記の製造法によるとシス型が高収率で(
47られる。
For example, 2-aminothiophenol and a glycitic acid ester represented by the general formula (in which Ar and R1 have the same meanings as above) are mixed in a solvent-free solution at a concentration of 100 to 130%.
By reacting at a temperature of 0.degree. C., the desired 2-hydroxypropionic acid ester derivative can be obtained. There are two stereoisomers of this compound, the /s type and the trans type, but 1) According to the production method described in II, the cis type is produced in high yield (
47.

また、前記一般式(n)におけるRが低級アシル基であ
る2−アシルオキ/プロピオ/酸エステル誘導体は新規
化合物でろって、前記のようにして得うした2−ヒドロ
キシプロピオン酸エステル誘導体のアシル化によっても
得られるが、一般式〇■(式中のAr及びR1は前記と
同じ意味をもつ)で示されるニトロ誘導体C特公昭46
−8982号公報記載の方法によって合成しうるうをア
シル化したのち、該ニトロ基を還元することKよっても
製造することができる。この製法においては、アシル化
剤として酢酸やプロピオン酸などの酸無水物、酸ハライ
ドなどが用いられ、またこれらのアシル化剤と前記一般
式(至)で示されるニトロ誘導体との反応は無溶媒又は
ベンゼン、クロロホルムなどの有機溶媒中そのま1か、
あるいはピリジンなどの塩基の存在下で行われる。この
場合の反応温度は溶媒やアシル化剤などの種類によって
異なるが、通常0〜100℃の範囲でらる。
Furthermore, the 2-acyloxy/propio/acid ester derivative in which R in the general formula (n) is a lower acyl group may be a new compound, and the 2-hydroxypropionate derivative obtained as described above may be acylated. Nitro derivative C represented by the general formula 〇■ (Ar and R1 in the formula have the same meanings as above), which can also be obtained by
It can also be produced by acylating a resin synthesized by the method described in JP-A-8982 and then reducing the nitro group. In this production method, acid anhydrides such as acetic acid and propionic acid, acid halides, etc. are used as acylating agents, and the reaction between these acylating agents and the nitro derivative represented by the above general formula (to) is carried out without a solvent. Or directly in an organic solvent such as benzene or chloroform,
Alternatively, it is carried out in the presence of a base such as pyridine. The reaction temperature in this case varies depending on the type of solvent, acylating agent, etc., but is usually in the range of 0 to 100°C.

このようにして得られた一般式罎 (式中のAr及びR1は前記と同じ意味をもち、R4は
低級アルキル基である) で示される新規化合物のアシルオギシニトロ誘導体の還
元は、通常ニトロ基の還元に用いられている方法、例え
ば亜鉛、鉄、スズなどの金属又はそれらの金属塩類と酸
又はアルカリとの反応を、111川する方法、あるいは
パラジウム−炭素を触媒とする接触環元法などによって
行うことができる1、このようにして、前記一般式(■
)における■(が低級アシル基である2−アシルオキ/
プロピオン酸エステル訪導体が得られる。
The reduction of the acylogycin nitro derivative of the novel compound represented by the general formula (in which Ar and R1 have the same meanings as above, and R4 is a lower alkyl group) is usually carried out using nitro Methods used for the reduction of groups, such as the method of reacting metals such as zinc, iron, tin, or their metal salts with acids or alkalis, or the catalytic reduction method using palladium-carbon as a catalyst. 1. In this way, the general formula (■
) in which ■ (is a lower acyl group) 2-acyloki/
A propionic acid ester visiting conductor is obtained.

本発明方法において用いる前記一般式(V)で示される
化合物においては、式中のR2及び」(5はそれぞれ低
級アルキル基、Yは低級アルキレン基及びZはハロゲン
原子であって、低級アルキル基としてはメチル基、エチ
ル基、プロピル基などが、低級アルキレン基としてはメ
チレン基、エチレン基、トリメチレン基などが、ハロゲ
ノ原子としては塩素原子、臭素原子などが挙げられる。
In the compound represented by the general formula (V) used in the method of the present invention, R2 and "(5) in the formula are each a lower alkyl group, Y is a lower alkylene group, and Z is a halogen atom, and as a lower alkyl group, Examples of lower alkylene groups include methylene, ethylene, trimethylene, and the like; examples of halogen atoms include chlorine, bromine, and the like.

本発明方法において用いる非プロトン性極性母媒として
は、例えばジメチルスルホキシド、、 N、N−ジメチ
ルホルムアミド、スルホラン、アセトニトリル、N、N
−ジメチルアセトアミドなどが挙げられるが、これらの
中でジメチルスルホキノドが好適である。また、水素化
金属としては、例えば水素化ナトリウムなどが用いられ
る。
Examples of the aprotic polar mother medium used in the method of the present invention include dimethyl sulfoxide, N,N-dimethylformamide, sulfolane, acetonitrile, N,N
-dimethylacetamide and the like, among which dimethylsulfoquinide is preferred. Further, as the metal hydride, for example, sodium hydride is used.

本発明方法を好適に実施するには、例えば前記一般式(
II)で示されるプロピオン酸エステル誘導体を前記の
非プロトン性極性溶媒に溶解したのち、水素化ナトリウ
ムなどの水素化金属を、該プロピオン酸エステル誘導体
に対して1〜3倍モル当量、好ましくは1〜1.2倍モ
ル当量加え、次いで前記一般式(ト)で示される化合物
を、該プロピオン酸エステル誘導体に対して1〜3倍モ
ル当量、好ましくは1〜1.5倍モル当量加えて反応さ
せたのち、生成した前記一般式(1)で示される1、5
−ベンゾチアゼピン誘導体を常法に従って反応液から単
離し精製すればよい。この場合、反応温度は溶媒や該プ
ロピオン酸エステル誘導体の種類によって異なるが、5
〜70℃の範囲が望ましく、特に10〜40℃の範囲が
適している。
In order to suitably carry out the method of the present invention, for example, the general formula (
After dissolving the propionic acid ester derivative represented by II) in the aprotic polar solvent, a hydrogenation metal such as sodium hydride is added in an amount of 1 to 3 molar equivalents, preferably 1 to 3 times the molar equivalent of the propionic acid ester derivative. ~1.2 times the molar equivalent is added, and then a compound represented by the general formula (g) is added in a 1 to 3 times molar equivalent, preferably 1 to 1.5 times the molar equivalent of the propionic acid ester derivative, and reacted. After that, the generated 1,5 shown in the general formula (1)
- The benzothiazepine derivative may be isolated from the reaction solution and purified according to a conventional method. In this case, the reaction temperature varies depending on the solvent and the type of the propionic acid ester derivative;
A range of 70°C to 70°C is desirable, and a range of 10 to 40°C is particularly suitable.

本発明の1,5−ベンゾチアゼピン誘導体の製法は、従
来の方法が3工程を要するのに対し、わずか1工程で、
しかも収率よく目的物が得られ、工業的方法として極め
て有利である。1 次に実施例によって本発明をさらに詳細に説明する。
The method for producing 1,5-benzothiazepine derivatives of the present invention requires only one step, whereas the conventional method requires three steps.
Furthermore, the desired product can be obtained in good yield, making it extremely advantageous as an industrial method. 1 Next, the present invention will be explained in more detail with reference to Examples.

実施例1 シス−2−(4−メトキシフェニル)−3−ヒドロキシ
−5−(2−(ジメチルアミノ)エチル]−z、a−ジ
ヒドロ−1,5−ベンゾチアゼピン−4(51()−オ
ン塩酸塩の合成 シス−2ごヒドロキシ−3−(2−アミノフェニル+、
+)−3−(4−メトキシフェニル) −7−ロピオン
酸メチル3.31をジメチルスルホキシド。
Example 1 Cis-2-(4-methoxyphenyl)-3-hydroxy-5-(2-(dimethylamino)ethyl]-z,a-dihydro-1,5-benzothiazepine-4(51()- Synthesis of 1-hydrochloride cis-2-hydroxy-3-(2-aminophenyl+,
+)-3-(4-methoxyphenyl)-7-methyl lopionate 3.31 to dimethyl sulfoxide.

20艷に溶解し、これに60重量%水素化ナトリウム0
.48 fを加えて室温で30分間かきまぜる。
20% by weight of sodium hydride.
.. Add 48 f and stir at room temperature for 30 minutes.

次いでN、N−ジメチルアミノエチルクロリド1.37
を加え、室温で7時間かきまぜたのち、酢酸で中和後、
水100dを加える。次にクロロホルム50ゴで2回抽
出し、抽出液を合わせて水洗し、無水硫酸す) IJウ
ムで乾燥したのち濃縮する。
Then N,N-dimethylaminoethyl chloride 1.37
was added, stirred at room temperature for 7 hours, and then neutralized with acetic acid.
Add 100 d of water. Next, extract twice with 50 g of chloroform, combine the extracts, wash with water, dry with anhydrous sulfuric acid, and concentrate.

得られた油状換金エタノールに溶解し、塩酸ガスを導入
後、エーテルを加えて結晶をろ取したのち、エタノール
から再結晶すると、針状晶としてシス−2−(4−メト
キシフェニル)−3−ヒドロキシ−s−[2−(ジメチ
ルアミノ)エチル〕−2,3−ジヒドロ−1,5−ベン
ゾチアゼピン−4(5H)−オン塩酸塩3.12が得ら
れた。収率75%、融点226〜228℃(分解)、水
晶は既知の方法で合成した標品と、TLC及び1.Rで
完全に一致した。
The obtained oil was dissolved in ethanol, hydrochloric acid gas was introduced, ether was added, the crystals were collected by filtration, and then recrystallized from ethanol to give cis-2-(4-methoxyphenyl)-3- as needle-shaped crystals. 3.12 of hydroxy-s-[2-(dimethylamino)ethyl]-2,3-dihydro-1,5-benzothiazepin-4(5H)-one hydrochloride were obtained. Yield 75%, melting point 226-228°C (decomposition), crystals were synthesized by a known method, and TLC and 1. Complete agreement with R.

実施例2 実施例1において60重量%水素化ナトリウム0.48
 rを用いる代りに0.9Orを用いる以外は、実施例
1と全く同様にして操作した。その結果、シス−2−(
4−メトキシフェニル)−3−ヒドロキシ−5−[2−
(ジメチルアミノ)エチルクー2.3−ジヒドロ−1,
5−ベンゾチアゼピン−4(5H)−オン塩酸塩1.9
2が得られた1、収率46% 実施例3 ンスー2−(4〜メトキシフエニル)−3−アセトキシ
−5−1:2−(ジメチルアミン)エチル)−2,3−
ジヒドロ−1,5−ベンゾチアゼピン−4(511)−
オン塩酸塩の合成 7スー2−アセチルオキシ−3−(2−アミノフェニル
チオ)−3−(4−メトギアフェニル)−プロピオン酸
メチル1.9gをジメチルスルホキシド207!に溶解
したのち、60 亜1ii’、%水素化ナトリウム0.
249を加えて室温で10分間かきまぜる。次いでN、
N−ジメチルアミノエチルクロリド0.72を加えて室
温で7 H,l、間かき1ぜノこのち、酢酸で中和後、
水100m1を加える。次にクロロホルム50rnlで
2回抽出し、抽出液を合わせて水洗し、無水硫酸ナトリ
ウムで乾燥したのち濃縮する。
Example 2 60% by weight sodium hydride in Example 1 0.48
The operation was carried out in exactly the same manner as in Example 1 except that 0.9Or was used instead of r. As a result, cis-2-(
4-methoxyphenyl)-3-hydroxy-5-[2-
(dimethylamino)ethylcou-2,3-dihydro-1,
5-Benzothiazepine-4(5H)-one hydrochloride 1.9
2 was obtained 1, yield 46% Example 3 N-2-(4-methoxyphenyl)-3-acetoxy-5-1:2-(dimethylamine)ethyl)-2,3-
Dihydro-1,5-benzothiazepine-4(511)-
Synthesis of 1-hydrochloride 7 1.9 g of methyl 2-acetyloxy-3-(2-aminophenylthio)-3-(4-methogyaphenyl)-propionate was dissolved in 207 g of dimethyl sulfoxide! After dissolving in 60% sodium hydride, 0.1% sodium hydride.
Add 249 and stir at room temperature for 10 minutes. Then N,
Add 0.72 of N-dimethylaminoethyl chloride and stir for 7 hours at room temperature for 1 hour, then neutralize with acetic acid.
Add 100ml of water. Next, the mixture is extracted twice with 50 rnl of chloroform, the extracts are combined, washed with water, dried over anhydrous sodium sulfate, and concentrated.

得られた油状物をシリカゲルによるカラムクロマトグラ
フィーに付し、クロロホルム−メタノール混液(3:2
V/V)で溶出して油状物を得る。
The obtained oil was subjected to column chromatography using silica gel, and a chloroform-methanol mixture (3:2
V/V) to give an oil.

次いで、この油状物をエタノールに溶解し、塩酸ガスを
導入して塩酸塩となし、エーテルを加えて結晶化させた
ところ、シス−2−(4−メトキシフェニル)−3−ア
セトキシ−5−(2−(ジメチルアミノ)エチル:]−
]2.3−ジヒドロー1,5−ベンゾチアゼピン4(5
H)−オン塩酸塩1.32が得られた。収率48%、融
点188〜182℃、水晶は既知の方法で合成した標品
と、TLC及び工Rで完全に一致した。
Next, this oily substance was dissolved in ethanol, hydrochloric acid gas was introduced to form a hydrochloride salt, and ether was added to crystallize it, resulting in cis-2-(4-methoxyphenyl)-3-acetoxy-5-( 2-(dimethylamino)ethyl:]-
]2.3-dihydro1,5-benzothiazepine 4(5
1.32 of H)-one hydrochloride was obtained. The yield was 48%, the melting point was 188-182°C, and the crystals were completely identical to the standard product synthesized by a known method by TLC and engineering.

参考例1 シス−2−ヒドロキシ−3−(2−アミノフェニルチオ
)−3−(4−メトキシフェニル)−プロピオン酸メチ
ルの合成 2−アミノチオフェノール14.Orと3−(4−メト
キンフェニル)グリジット酸メチル20.82を窒素ガ
ス気流下110℃のオイルバス中に入れ、10時間かき
1ぜる。反応後、メタノールを加え結晶化させたのち、
ろ取してメタノールから再結晶すると、シス−2−ヒド
ロキシ−3−(2−アミンフェニルチオ)−3−(4−
メトキシフェニル)−プロピオン酸メチル24.8 f
が得られた。
Reference Example 1 Synthesis of methyl cis-2-hydroxy-3-(2-aminophenylthio)-3-(4-methoxyphenyl)-propionate 2-aminothiophenol 14. Or and 20.82 g of methyl 3-(4-methquinphenyl)glysitate were placed in an oil bath at 110° C. under a nitrogen gas stream and stirred for 10 hours. After the reaction, add methanol to crystallize,
When collected by filtration and recrystallized from methanol, cis-2-hydroxy-3-(2-aminephenylthio)-3-(4-
Methoxyphenyl)-propionate 24.8 f
was gotten.

収率74%、融点92〜9:3℃ 参考例2 シス−2−アセチルオキシ−3−(4−メトキシフェニ
ル)−3−(2−ニトロフェニルチオ) −フロピオン
酸メチルの合成 シス−2−ヒドロキシ−3−(4−メトギアフェニル)
−3−(2−ニトロフェニルチオ)−フロピオン酸メチ
ル20.OS’にピリジン50++にと無水酢酸20m
1を加え、60℃で3時間がき一土ぜる。
Yield 74%, melting point 92-9:3°C Reference Example 2 Synthesis of cis-2-acetyloxy-3-(4-methoxyphenyl)-3-(2-nitrophenylthio)-methyl phlopionate cis-2- Hydroxy-3-(4-methogyaphenyl)
Methyl -3-(2-nitrophenylthio)-furopionate20. OS', pyridine 50++ and acetic anhydride 20m
Add 1 and boil at 60℃ for 3 hours.

次いで室温まで冷却後、氷水2.00111e中に加え
、酢酸エチル300dで2回抽出し、抽出液を合わせて
水洗したのち、無水硫酸ナトリウムで乾燥後濃縮する。
After cooling to room temperature, the mixture was added to 2.00111e of ice water, extracted twice with 300d of ethyl acetate, and the extracts were combined, washed with water, dried over anhydrous sodium sulfate, and concentrated.

濃縮物をエタノールで内結晶して黄色釧状晶のシス−2
−アセチルオキ/−3−(4−メI・キンフェニル)−
3−(2−ニトロフェニルチオ)−プロピオン酸メチル
20.5 fをイ()る。収率95%、融点103−1
05℃、IRv”’cm ’ : 17(30゜173
8.1508.1338.1210参考例3 シス−2−アセチルオキシ−3−(2−アミノフェニル
チオ)−a−(4−メトキシフェニル)−プロピオン酸
メチルの合成 シス−2−アセチルオキシ−3−(4−メトキシフェニ
ル)−3−(2−ニトロフェニルチオ)−プロピオン酸
メチル3.02をメタノール50meに懸濁させ、5%
P(1−Cx、oyを加えて室温で接触還元を6時間行
う。反応後、ろ過してろ液を減圧濃縮すると、油状物の
シス−2−アセチルオギシー3−(2−アミノフェニル
チオ)−3−(4−メトキシフェニル)−フロピオン酸
メチル2.8KI3r −1。
The concentrate was internally crystallized with ethanol to give yellow cylindrical crystals of cis-2.
-acetyloki/-3-(4-meI-quinphenyl)-
Add 20.5 f of methyl 3-(2-nitrophenylthio)-propionate. Yield 95%, melting point 103-1
05°C, IRv”'cm': 17 (30°173
8.1508.1338.1210 Reference Example 3 Synthesis of cis-2-acetyloxy-3-(2-aminophenylthio)-a-(4-methoxyphenyl)-methyl propionate cis-2-acetyloxy-3- 3.02 methyl (4-methoxyphenyl)-3-(2-nitrophenylthio)-propionate was suspended in 50me of methanol, and 5%
P(1-Cx, oy is added and catalytic reduction is carried out at room temperature for 6 hours. After the reaction, it is filtered and the filtrate is concentrated under reduced pressure to produce an oily substance, cis-2-acetyl-oxy-3-(2-aminophenylthio). Methyl -3-(4-methoxyphenyl)-furopionate 2.8KI3r -1.

tが得られた。収率100%、IRv1naXcrn。t was obtained. 100% yield, IRv1naXcrn.

3450.3350.1608.1508特許出願人 
東進ケミカル株式会社 代理人 阿 形 明
3450.3350.1608.1508 Patent Applicant
Toshin Chemical Co., Ltd. Agent Akira Agata

Claims (1)

【特許請求の範囲】 ■ 一般式 (式中のArは低級アルコギン基で置換されたフェニル
基、Rは水素原子又は低級つ′シル基及びR1は低級ア
ルキル基である) で示される化合物を、非プロトン性極性晶媒中水素化金
属の存在下に、一般式 (式中のR2及びR3はそれぞれ低級アルギル基、Yは
低級アルキレン基及びZはハロゲン原子である) で示される化合物と縮合反応させることを特徴とする、
一般式 (式中のAr、 R,R2、R3及びYは前記と同じ意
味をもつ) で示される1、5−ベンゾチアセビン誘導体の製法0 2 非プロトン性極性溶媒がジメチルスルホキシドであ
る特許請求の範囲第1項記載の製法。 3 水素化金属が水素化す) IJウムである特許請求
の範囲第1項又は第2項記載の製法。
[Claims] ■ A compound represented by the general formula (in the formula, Ar is a phenyl group substituted with a lower alkogine group, R is a hydrogen atom or a lower alkyl group, and R1 is a lower alkyl group), Condensation reaction with a compound represented by the general formula (in the formula, R2 and R3 are each a lower argyl group, Y is a lower alkylene group, and Z is a halogen atom) in the presence of a metal hydride in an aprotic polar crystal medium. characterized by causing
A process for producing a 1,5-benzothiacebin derivative represented by the general formula (Ar, R, R2, R3 and Y in the formula have the same meanings as above) Claims in which the aprotic polar solvent is dimethyl sulfoxide The manufacturing method described in paragraph 1. 3. The manufacturing method according to claim 1 or 2, wherein the hydriding metal is IJium.
JP18677883A 1983-10-07 1983-10-07 Production of 1,5-benzothiazepine derivative Pending JPS6078973A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18677883A JPS6078973A (en) 1983-10-07 1983-10-07 Production of 1,5-benzothiazepine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18677883A JPS6078973A (en) 1983-10-07 1983-10-07 Production of 1,5-benzothiazepine derivative

Publications (1)

Publication Number Publication Date
JPS6078973A true JPS6078973A (en) 1985-05-04

Family

ID=16194437

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18677883A Pending JPS6078973A (en) 1983-10-07 1983-10-07 Production of 1,5-benzothiazepine derivative

Country Status (1)

Country Link
JP (1) JPS6078973A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908469A (en) * 1988-05-18 1990-03-13 Marion Laboratories, Inc. 2-Hydroxy-propanoic acid acyclic alkyl esters for benzothiazepines
JPH02190195A (en) * 1989-01-19 1990-07-26 Rikagaku Kenkyusho Production of optically active propionic acid ester compound
EP0450705A1 (en) * 1990-03-31 1991-10-09 Dsm N.V. Process for preparing 1,5-benzothiazepin derivatives

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908469A (en) * 1988-05-18 1990-03-13 Marion Laboratories, Inc. 2-Hydroxy-propanoic acid acyclic alkyl esters for benzothiazepines
JPH02190195A (en) * 1989-01-19 1990-07-26 Rikagaku Kenkyusho Production of optically active propionic acid ester compound
JPH0578311B2 (en) * 1989-01-19 1993-10-28 Rikagaku Kenkyusho
EP0450705A1 (en) * 1990-03-31 1991-10-09 Dsm N.V. Process for preparing 1,5-benzothiazepin derivatives

Similar Documents

Publication Publication Date Title
FI87778B (en) ANALOGIFICATION OF ANTIDOPAMINERIAL ACTIVATION THIAZEPIN
US4582918A (en) Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
EP0098892B1 (en) Process for preparing 1,5-benzothiazepine derivatives
JPH0376307B2 (en)
US4963671A (en) Process for resolving chiral intermediates used in making calcium channel blockers
EP0395323B1 (en) Process for preparing 1,5-benzothiazepine derivatives
JPS6078973A (en) Production of 1,5-benzothiazepine derivative
JPS6317831B2 (en)
RU2233275C2 (en) Method for preparing derivatives of dibenzothiazepine
KR0173317B1 (en) Process for preparation of 6-(substituted-aminopropionyl)derivatives of forskolin
JP2860300B2 (en) 8-Hydroxy-3- (4-methoxyphenyl) -3- (2-aminophenylthio) propionic acid 8'-phenylmenthyl ester and method for producing the same
US4677214A (en) Intermediates for preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
RU2329253C2 (en) Method of obtaining derivatives of substituted imidazole and intermediate compounds, used in method
JP3865096B2 (en) Method for producing dibenzothiazepine derivative
US4640930A (en) Naphtho(1,8-bc)-1,5-thiazocinones
JP4336913B2 (en) Method for producing amide derivative
US5128468A (en) Process for preparing 2-aryl-3-hydroxy-cis-2,3-dihydro-1,5-benzothiazepin-4(5H)-ones and their derivatives
US5310904A (en) Process for preparing optically active benzothiazepine compounds by asymmetric reduction
EP0341562A1 (en) Process for preparing(+)-and(-)-beta-[(2-amino-1-naphthalenyl)thio]-alpha-hydroxy-4-methoxy-benzenepropanoic acid
KR860000781B1 (en) Process for preparing 1,5-benzothiazephine derivatives
EP0016665B1 (en) Process for the preparation of xanthone derivatives
JP2551375B2 (en) Process for producing 1,5-benzothiazepine derivative
FI77240C (en) FRAMSTAELLNINGSFOERFARANDE AV 1,5-BENZOTHIAZEPINDERIVAT.
JPH0573749B2 (en)
JPH01128974A (en) Production of 1,5-benzothiazepin derivative